ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

In Brief: Walter To Retire, Search Starts For New DEA Deputy; Mary Fink Retires; NCCP Seeks Director

January 27, 1984

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013

NCI Community Intervention Trial Reports

March 10, 1995

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990